APEX1 Gene Amplification and Its Protein Overexpression in Osteosarcoma: Correlation with Recurrence, Metastasis, and Survival

Jilong Yang; Da Yang; David Cogdell; Xiaoling Du; Haixin Li; Yi Pang; Yan Sun; Limei Hu; Baocun Sun; Jonathan Trent; Kexin Chen; Wei Zhang

doi:10.1177/153303461000900205

Back

APEX1 Gene Amplification and Its Protein Overexpression in Osteosarcoma: Correlation with Recurrence, Metastasis, and Survival

Journal article

Peer reviewed

APEX1 Gene Amplification and Its Protein Overexpression in Osteosarcoma: Correlation with Recurrence, Metastasis, and Survival

Jilong Yang, Da Yang, David Cogdell, Xiaoling Du, Haixin Li, Yi Pang, Yan Sun, Limei Hu, Baocun Sun, Jonathan Trent, …

Technology in cancer research & treatment, Vol.9(2), pp.161-169

2010-04

DOI: https://doi.org/10.1177/153303461000900205

PMID: 20218738

Metrics

18 Record Views

44 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.152 Molecular & Cell Biology - DNA Damage; 1.152.251 Nucleotide Excision Repair
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: APEX1 Gene Amplification and Its Protein Overexpression in Osteosarcoma: Correlation with Recurrence, Metastasis, and Survival
Creators: Jilong Yang - Departments of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Hospital and Institute, Tianjin, 30060, China, Departments of Pathology, University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030, USA
Da Yang - Departments of Pathology, University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030, USA
David Cogdell - Departments of Pathology, University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030, USA
Xiaoling Du - Department of Diagnostics, Tianjin Medical University, Tianjin, 30060, China
Haixin Li - Epidemiology and Biostatistics, Tianjin Medical University Cancer Hospital and Institute, Tianjin, 30060, China
Yi Pang - Pathology, Tianjin Medical University Cancer Hospital and Institute, Tianjin, 30060, China
Yan Sun - Pathology, Tianjin Medical University Cancer Hospital and Institute, Tianjin, 30060, China
Limei Hu - Departments of Pathology, University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030, USA
Baocun Sun - Pathology, Tianjin Medical University Cancer Hospital and Institute, Tianjin, 30060, China
Jonathan Trent - Sarcoma Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030, USA
Kexin Chen - Epidemiology and Biostatistics, Tianjin Medical University Cancer Hospital and Institute, Tianjin, 30060, China
Wei Zhang - Departments of Pathology, University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030, USA
Publication Details: Technology in cancer research & treatment, Vol.9(2), pp.161-169
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 20218738
Record Identifier: 991031559959002976